Helping you help patients
Helping you manage patient outcomes with the educational resources, clinical data, and product information you need, whenever you need them.
Primary hyperoxaluria type 1 (PH1) is a rare genetic disorder that can lead to recurrent kidney stones and progressive kidney damage1,2
Actor portrayals
PH1 clinical education
Learn about warning signs, disease
progression, and management
options.
Resource library
Access helpful PH1
treatment-related guides.
PH1 diagnosis
Explore recommended tests and
screenings to help diagnose PH1.
Review the PH1 basics
PH1 is a rare and progressive genetic disorder causing oxalate overproduction by the liver that can result in recurrent kidney stones, progressive kidney damage, and in some cases, life-threatening systemic disease.1,2
Understand how PH1 is diagnosed
Stay informed about PH1 warning signs, when and how to test for PH1, and recommendations for diagnosis.
Learn about patient resources
Novo Nordisk is dedicated to providing affordability and access resources for your eligible patients through the NovoCare® support program.
Connect with a Novo Nordisk representative
If you have questions about our treatment for PH1, your local representative is here to help.
Have you created your novoMEDLINK™ account?
Receive disease-state information, product updates, and more—all curated to match your interests and expertise.
References:
- Lai C, Pursell N, Gierut J, et al. Specific inhibition of hepatic lactate dehydrogenase reduces oxalate production in mouse models of primary hyperoxaluria. Mol Ther. 2018;26(8):1983-1995. doi:10.1016/ j.ymthe.2018.05.016
- Soliman NA, Nabhan MM, Abdelrahman SM, et al. Clinical spectrum of primary hyperoxaluria type 1: experience of a tertiary center. Nephrol Ther. 2017;13(3):176-182. doi:10.1016/j.nephro.2016.08.002